MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1853.03%
Quick Ratio
1853.03%
Cash Ratio
255.93%
Debt to Asset Ratio
6.13%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Preferred stock-Series ANon Voti...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
162,007
97,185
85,721
64,897
Marketable securities
983,339
644,282
670,812
421,301
Prepaid expenses and other current assets
27,657
22,486
21,248
18,406
Total current assets
1,173,003
763,953
777,781
504,604
Other non-current assets
-
-
0
0
Total assets
1,173,003
763,953
777,781
504,604
Accounts payable-Nonrelated Party
5,722
5,692
8,904
7,457
Cvr liability
31,350
50,260
22,820
11,020
Accrued and other current liabilities
26,184
29,160
26,947
23,827
Related party accounts payable-Related Party
46
50
14
3,970
Total current liabilities
63,302
85,162
58,685
46,274
Non-current cvr liability
7,270
6,690
3,860
3,230
Other non-current liabilities
1,290
1,290
-
-
Total liabilities
71,862
93,142
62,545
49,504
Preferred stock-Series ANon Voting Convertible Preferred Stock
146,425
146,425
146,425
146,425
Preferred stock-Series BNon Voting Convertible Preferred Stock
0
9,395
9,395
9,395
Preferred stock-Preferred Stock Excluding Series AAnd BNon Voting Convertible Preferred Stock
0
0
0
0
Common stock, 0.0001 par value 400,000,000 shares authorized as of june30, 2026 and december31, 2025 88,064,133 shares and 78,189,811 shares issued and outstanding as of june30, 2026 and december31, 2025, respectively
16
15
15
13
Additional paid-in capital
2,189,936
1,712,383
1,686,167
1,363,581
Accumulated other comprehensive (loss) income
-2,396
-767
869
791
Accumulated deficit
-1,232,840
-1,196,640
-1,127,635
-1,065,105
Total stockholders equity
1,101,141
670,811
715,236
455,100
Total liabilities, convertible preferred stock and stockholders equity
1,173,003
763,953
777,781
504,604
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$983,339K (121.01%↑ Y/Y)Cash and cashequivalents$162,007K (98.39%↑ Y/Y)Prepaid expenses andother current assets$27,657K (125.73%↑ Y/Y)Total current assets$1,173,003K (117.69%↑ Y/Y)Total assets$1,173,003K (117.69%↑ Y/Y)Total liabilities,convertible preferred stock...$1,173,003K (117.69%↑ Y/Y)Total stockholdersequity$1,101,141K (141.60%↑ Y/Y)Total liabilities$71,862K (-13.48%↓ Y/Y)Accumulated deficit-$1,232,840K (-16.98%↓ Y/Y)Accumulated othercomprehensive (loss) income-$2,396K (-627.75%↓ Y/Y)Additional paid-in capital$2,189,936K (61.81%↑ Y/Y)Total currentliabilities$63,302K (-23.79%↓ Y/Y)Non-current cvr liability$7,270K Other non-currentliabilities$1,290K Preferred stock-SeriesANon Voting...$146,425K (0.00%↑ Y/Y)Common stock, 0.0001par value...$16K (23.08%↑ Y/Y)Cvr liability$31,350K (-47.66%↓ Y/Y)Accrued and othercurrent liabilities$26,184K (34.86%↑ Y/Y)Accountspayable-Nonrelated Party$5,722K (54.15%↑ Y/Y)Related party accountspayable-Related Party$46K (48.39%↑ Y/Y)

Spyre Therapeutics, Inc. (SYRE)

Spyre Therapeutics, Inc. (SYRE)